1. Home
  2. Analysis
  3. Cefixime
  4. Simponi

Cefixime and Simponi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefixime (cefixime) and Simponi (golimumab). Common drug interactions include drug ineffective among females.

The phase IV clinical study analyzes what interactions people have when they take Cefixime and Simponi. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Cefixime?

Cefixime has active ingredients of cefixime. eHealthMe is studying from 3,237 Cefixime users. Check the latest studies of Cefixime.

What is Simponi?

Simponi has active ingredients of golimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 86,328 Simponi users. Check the latest studies of Simponi.

On Jul, 09, 2026

35 people who take Cefixime and Simponi together, and have interactions are studied.

Cefixime and Simponi drug interactions.

What are the common drug interactions of Cefixime and Simponi, by gender? *:

female:

  1. Drug ineffective
  2. Drug intolerance (drug sensitivity)
  3. Decreased appetite
  4. Disability
  5. Headache (pain in head)
  6. Hypercholesterolaemia (high levels of cholesterol in the blood)
  7. Infection
  8. Joint stiffness
  9. Joint swelling
  10. Limb deformity (functional disability of leg)

male:

n/a

What are the common drug interactions of Cefixime and Simponi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug ineffective
  2. Drug intolerance (drug sensitivity)
  3. Skin lesion
  4. Tooth abscess (pus formation in tooth)
  5. Vaginal infection

30-39:

n/a

40-49:

  1. Bone disorder
  2. Ankle fracture
  3. Hypercholesterolaemia (high levels of cholesterol in the blood)
  4. Infection
  5. Joint stiffness
  6. Joint swelling
  7. Limb deformity (functional disability of leg)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Mood swings (an extreme or rapid change in mood)
  10. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Ankylosing Spondylitis (type of arthritis affecting the spine): 28 people, 80.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cefixime and Simponi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefixime and Simponi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefixime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Simponi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefixime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Simponi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on cefixime and golimumab (the active ingredients of Cefixime and Simponi, respectively), and Cefixime and Simponi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.